ロード中...
Mechanistic Validation of a Clinical Lead Stapled Peptide that Reactivates p53 by Dual HDM2 and HDMX Targeting
Hydrocarbon-stapled peptides that display key residues of the p53 transactivation domain have emerged as bona fide clinical candidates for reactivating the tumor suppression function of p53 in cancer by dual targeting of the negative regulators HDM2 and HDMX. A recent study questioned the mechanisti...
保存先:
| 出版年: | Oncogene |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386833/ https://ncbi.nlm.nih.gov/pubmed/27721413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.361 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|